Carl Schmid and Kevin Herwig offer updates at USCHA on Braidwood v Becerra, which challenges ACA’s preventive services coverage requirement, and discuss the amicus brief filed by HIV+Hepatitis Policy Institute and supported by 24 HIV and hepatitis organizations and other amici briefs filed by other groups.
Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, is excited about the new Eliminate Hepatitis C (HCV) program put forth by the Biden Administration and being led by former NIH Director Francis Collins, MD, PhD, who is serving as a scientific advisor to the Biden Administration. “This is something we have been asking for years…We know we can end hepatitis C,” Schmid stated.
On World Hepatitis Day, Contagion Live community podcast featured HIV+Hep’s Carl Schmid discussing the challenges in the fight against viral hepatitis: “Every 30 seconds someone is dying of hepatitis, & the sad thing is people don’t even know about it. Like HIV, there is so much stigma. . . . It all comes down to testing. This is an infectious disease, remarkably, that can be cured. But we need more resources.”